$1.43 Billion is the total value of QVT Financial LP's 56 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD | $416,648,000 | -20.9% | 129,393,817 | 0.0% | 29.07% | -12.4% | ||
NXST | NEXSTAR MEDIA GROUP INC | $27,653,000 | +2.4% | 165,735 | 0.0% | 1.93% | +13.5% | |
NNI | NELNET INCcl a | $16,999,000 | -7.1% | 214,665 | 0.0% | 1.19% | +2.9% | |
MICROSTRATEGY INCnote 0.750%12/1 | $15,307,000 | +22.4% | 20,000,000 | 0.0% | 1.07% | +35.5% | ||
MMYT | MAKEMYTRIP LIMITED MAURITIUS | $15,073,000 | +19.6% | 490,981 | 0.0% | 1.05% | +32.5% | |
GS | GOLDMAN SACHS GROUP INC | $14,051,000 | -1.3% | 47,949 | 0.0% | 0.98% | +9.3% | |
BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $12,803,000 | -2.2% | 47,946 | 0.0% | 0.89% | +8.2% | |
CLOVIS ONCOLOGY INCnote 4.500% 8/0 | $12,750,000 | -8.6% | 21,000,000 | 0.0% | 0.89% | +1.3% | ||
ARGX | ARGENX SEsponsored adr | $11,473,000 | -6.8% | 32,498 | 0.0% | 0.80% | +3.2% | |
LILAK | LIBERTY LATIN AMERICA LTD | $10,759,000 | -21.1% | 1,749,467 | 0.0% | 0.75% | -12.6% | |
SEA LTDnote 0.250% 9/1 | $10,439,000 | -5.2% | 15,000,000 | 0.0% | 0.73% | +4.9% | ||
ILMN | ILLUMINA INC | $10,350,000 | +3.5% | 54,250 | 0.0% | 0.72% | +14.6% | |
STRIDE INCnote 1.125% 9/0 | $10,216,000 | +2.5% | 10,000,000 | 0.0% | 0.71% | +13.5% | ||
MSTR | MICROSTRATEGY INCput | $9,891,000 | +29.2% | 46,600 | 0.0% | 0.69% | +43.2% | |
NYT | NEW YORK TIMES COcl a | $9,112,000 | +3.0% | 316,947 | 0.0% | 0.64% | +14.2% | |
EAGLE BULK SHIPPING INCnote 5.000% 8/0 | $7,053,000 | -10.3% | 4,850,000 | 0.0% | 0.49% | -0.6% | ||
MAKEMYTRIP LIMITED MAURITIUSnote 2/1 | $6,811,000 | +6.6% | 6,500,000 | 0.0% | 0.48% | +17.9% | ||
IMGN | IMMUNOGEN INC | $6,577,000 | +6.2% | 1,375,900 | 0.0% | 0.46% | +17.7% | |
IOVA | IOVANCE BIOTHERAPEUTICS INC | $6,501,000 | -13.2% | 678,564 | 0.0% | 0.45% | -3.8% | |
TNK | TEEKAY TANKERS LTDcl a | $5,059,000 | +56.2% | 183,700 | 0.0% | 0.35% | +73.0% | |
H WORLD GROUP LTDnote 0.375%11/0 | $4,739,000 | -2.8% | 4,780,000 | 0.0% | 0.33% | +7.8% | ||
GTN | GRAY TELEVISION INC | $4,174,000 | -15.2% | 291,452 | 0.0% | 0.29% | -6.1% | |
LBTYA | LIBERTY GLOBAL PLC | $3,785,000 | -25.9% | 242,800 | 0.0% | 0.26% | -18.0% | |
MSTR | MICROSTRATEGY INCcl a new | $3,495,000 | +29.2% | 16,465 | 0.0% | 0.24% | +43.5% | |
JD | JD.COM INCspon adr cl a | $3,247,000 | -21.7% | 64,548 | 0.0% | 0.23% | -13.0% | |
FRG | FRANCHISE GROUP INC | $3,162,000 | -30.7% | 130,120 | 0.0% | 0.22% | -23.0% | |
JOYY INCnote 0.750% 6/1 | $932,000 | +4.6% | 1,000,000 | 0.0% | 0.06% | +16.1% | ||
ACMR | ACM RESH INC | $874,000 | -25.9% | 70,119 | 0.0% | 0.06% | -17.6% | |
BABA | ALIBABA GROUP HLDG LTDsponsored ads | $770,000 | -29.6% | 9,626 | 0.0% | 0.05% | -21.7% | |
BIDU | BAIDU INCspon adr rep a | $611,000 | -21.0% | 5,200 | 0.0% | 0.04% | -12.2% | |
TIL | INSTIL BIO INC | $477,000 | +4.6% | 98,644 | 0.0% | 0.03% | +13.8% | |
MRSN | MERSANA THERAPEUTICS INC | $424,000 | +46.7% | 62,657 | 0.0% | 0.03% | +66.7% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $375,000 | +2.2% | 4,429 | 0.0% | 0.03% | +13.0% | |
SRPT | SAREPTA THERAPEUTICS INC | $345,000 | +47.4% | 3,117 | 0.0% | 0.02% | +60.0% | |
GDS | GDS HLDGS LTDsponsored ads | $313,000 | -47.0% | 17,700 | 0.0% | 0.02% | -40.5% | |
ACAD | ACADIA PHARMACEUTICALS INC | $321,000 | +16.3% | 19,613 | 0.0% | 0.02% | +29.4% | |
APPHW | APPHARVEST INC*w exp 01/30/202 | $170,000 | -15.0% | 500,000 | 0.0% | 0.01% | -7.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-07 |
SC 13G/A | 2024-03-07 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
4 | 2023-10-02 |
144 | 2023-09-28 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-05-18 |
13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.